Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 13, Number 1, January 2002   [Index by Author] 
Other Issues: Previous Next  

Down Lung cancer
Down News
Down Editorials
Down Reviews
Down Debates
Down Breast cancer
Down Gastrointestinal tumours
Down Urogenital tumours
Down Hematologic malignancies
Down Head and neck cancer
Down Sarcomas
Down Phase I studies
Down Clinical cases
Down Letters to the Editor
Down Book reviews


[Search ALL Issues]


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Lung cancer Back

Y.-M. Chen, R.-P. Perng, Y.-C. Lee, J.-F. Shih, C.-S. Lee, C.-M. Tsai, and J. Whang-Peng
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
Ann Oncol 2002 13: 108-115; doi:10.1093/annonc/mdf009 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

N. H. Hanna, A. B. Sandler, P. J. Loehrer Sr, R. Ansari, S. H. Jung, K. Lane, and L. H. Einhorn
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study
Ann Oncol 2002 13: 95-102; doi:10.1093/annonc/mdf014 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

I. Monnet, H. de Cremoux, P. Soulié, S. Saltiel-Voisin, M. Bekradda, J.-C. Saltiel, E. Brain, O. Rixe, Y. Yataghene, J.-L. Misset, and E. Cvitkovic
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study
Ann Oncol 2002 13: 103-107; doi:10.1093/annonc/mdf006 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

News Back

News
Ann Oncol 2002 13: 1-5; doi:10.1093/annonc/mdf099 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Editorials Back

D. J. Kerr
Per ardua ad astra
Ann Oncol 2002 13: 7; doi:10.1093/annonc/mdf094 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

J. Baselga
Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing
Ann Oncol 2002 13: 8-9; doi:10.1093/annonc/mdf092 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

J. R. Bertino
Modulation of 5-fluorouracil/leucovorin by trimetrexate—did it work?
Ann Oncol 2002 13: 10-11; doi:10.1093/annonc/mdf086 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

R. S. Kerbel, G. Klement, K. I. Pritchard, and B. Kamen
Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncology clinic
Ann Oncol 2002 13: 12-15; doi:10.1093/annonc/mdf093 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

P. Boyle
Faecal occult blood testing (FOBT) as screening for colorectal cancer: the current controversy
Ann Oncol 2002 13: 16-18; doi:10.1093/annonc/mdf066 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

N. Gray and P. Boyle
Regulation of cigarette emissions
Ann Oncol 2002 13: 19-21; doi:10.1093/annonc/mdf007 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Reviews Back

J. S. Whelan, R. J. Burcombe, J. Janinis, A. M. Baldelli, and A. M. Cassoni
A systematic review of the role of pulmonary irradiation in the management of primary bone tumours
Ann Oncol 2002 13: 23-30; doi:10.1093/annonc/mdf047 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Debates Back

C. La Vecchia
Fecal occult blood screening for colorectal cancer: open issues
Ann Oncol 2002 13: 31-34; doi:10.1093/annonc/mdf073 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

C. S. McArdle
Faecal occult blood testing for colorectal cancer
Ann Oncol 2002 13: 35-39; doi:10.1093/annonc/mdf069 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

A. B. Lowenfels
Fecal occult blood testing as a screening procedure for colorectal cancer
Ann Oncol 2002 13: 40-43; doi:10.1093/annonc/mdf074 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

H. Bleiberg
Hemoccult should no longer be used for the screening of colorectal cancer
Ann Oncol 2002 13: 44-46; doi:10.1093/annonc/mdf071 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

M. Crespi and D. Lisi
Is colorectal cancer screening by fecal occult blood feasible?
Ann Oncol 2002 13: 47-50; doi:10.1093/annonc/mdf070 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

H. Strul and N. Arber
Fecal occult blood test for colorectal cancer screening
Ann Oncol 2002 13: 51-56; doi:10.1093/annonc/mdf076 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

P. Autier
Should organised faecal occult blood test screening be established?
Ann Oncol 2002 13: 57-60; doi:10.1093/annonc/mdf072 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

M. J. Barry
Fecal occult blood testing for colorectal cancer: a perspective
Ann Oncol 2002 13: 61-64; doi:10.1093/annonc/mdf075 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Breast cancer Back

N. Normanno, M. Campiglio, A. De Luca, G. Somenzi, M. Maiello, F. Ciardiello, L. Gianni, D. S. Salomon, and S. Menard
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth
Ann Oncol 2002 13: 65-72; doi:10.1093/annonc/mdf020 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

M. Colleoni, A. Rocca, M. T. Sandri, L. Zorzino, G. Masci, F. Nolè, G. Peruzzotti, C. Robertson, L. Orlando, S. Cinieri, F. de Braud, G. Viale, and A. Goldhirsch
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
Ann Oncol 2002 13: 73-80; doi:10.1093/annonc/mdf013 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Gastrointestinal tumours Back

C. J. A. Punt, H. J. Keizer, J. Douma, T. Skovsgaard, J. Schüller, E. W. Muller, C. H. H. Ten Napel, J. J. Croles, H. Lochs, J. Zhang, and L. Hammershaimb
Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study
Ann Oncol 2002 13: 81-86; doi:10.1093/annonc/mdf045 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

C. D. Blanke, J. Shultz, J. Cox, M. Modiano, R. Isaacs, B. Kasimis, R. Schilsky, J. Fleagle, M. Moore, N. Kemeny, D. Carlin, L. Hammershaimb, D. Haller, and Participating investigators
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer
Ann Oncol 2002 13: 87-91; doi:10.1093/annonc/mdf043 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

C. J. A. Punt, C. D. Blanke, J. Zhang, and L. Hammershaimb
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer
Ann Oncol 2002 13: 92-94; doi:10.1093/annonc/mdf044 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Urogenital tumours Back

C. M. George, N. J. Vogelzang, B. I. Rini, F. J. Geoffroy, P. Kollipara, and W. M. Stadler
A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma
Ann Oncol 2002 13: 116-120; doi:10.1093/annonc/mdf008 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

M. Scholz, M. Zehender, G. N. Thalmann, M. Borner, H. Thöni, and U. E. Studer
Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis
Ann Oncol 2002 13: 121-124; doi:10.1093/annonc/mdf003 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

K. Fizazi, K.-A. Do, X. Wang, L. Finn, C. J. Logothetis, and R. J. Amato
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial
Ann Oncol 2002 13: 125-134; doi:10.1093/annonc/mdf005 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Hematologic malignancies Back

H. Bertz, G. Illerhaus,, H. Veelken, and J. Finke
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens
Ann Oncol 2002 13: 135-139; doi:10.1093/annonc/mdf010 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

T. Rüdiger, D. D. Weisenburger, J. R. Anderson, J. O. Armitage, J. Diebold, K. A. MacLennan, B. N. Nathwani, F. Ullrich, and H. K. Müller-Hermelink
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project
Ann Oncol 2002 13: 140-149; doi:10.1093/annonc/mdf033 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Head and neck cancer Back

K.-F. Foo, E.-H. Tan, S.-S. Leong, J. T. S. Wee, T. Tan, K.-W. Fong, L. Koh, B.-C. Tai, L.-G. Lian, and D. Machin
Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type
Ann Oncol 2002 13: 150-156; doi:10.1093/annonc/mdf002 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Sarcomas Back

C. Franzius, H. E. Daldrup-Link, A. Wagner-Bohn, J. Sciuk, W. L. Heindel, H. Jürgens, and O. Schober
FDG–PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging
Ann Oncol 2002 13: 157-160; doi:10.1093/annonc/mdf012 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Phase I studies Back

T. De Pas, G. Curigliano, G. Masci, C. Catania, A. Comandone, C. Boni, A. Tucci, O. Pagani, E. Marrocco, and F. de Braud
Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas
Ann Oncol 2002 13: 161-166; doi:10.1093/annonc/mdf004 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Clinical cases Back

G. M. Marx, A. Boyce, and D. Goldstein
Elevated {alpha}-foetoprotein and hepatic metastases—it’s not always what it seems!
Ann Oncol 2002 13: 167-169; doi:10.1093/annonc/mdf015 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

P. Sagaster, N. Zojer, G. Dekan, and H. Ludwig
A paraneoplastic syndrome mimicking extrauterine pregnancy
Ann Oncol 2002 13: 170-172; doi:10.1093/annonc/mdf011 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

W. Mermershtain, H. Schulman, Y. Hertzanu, and Y. Cohen
Massive cavitation of solid pulmonary metastatic lesions in a breast cancer patient: a case report
Ann Oncol 2002 13: 173-174; doi:10.1093/annonc/mdf001 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Letters to the Editor Back

C. M. Balch and M. C. Mihm
Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9–11)
Ann Oncol 2002 13: 175-176; doi:10.1093/annonc/mdf060 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Book reviews Back

G. D. Beretta
Modern Management of Cancer of the Rectum
Ann Oncol 2002 13: 177; doi:10.1093/annonc/mdf068 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

M. Tomirotti
Cancer and Pregnancy
Ann Oncol 2002 13: 177-178; doi:10.1093/annonc/mdf067 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.